Corine Bertolotto

7PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersMolecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 02, 2025
Systematic identification of lincRNA-derived immunogenic peptides in melanoma.

Emilie Dupré, Amélie Guiho, Tiffany Beauvais

|Jun 13, 2024
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.

Luca Di Leo, Chiara Pagliuca, Ali Kishk

|Nov 15, 2023
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.

Sarah Proteau, Imène Krossa, Chrystel Husser

|Jul 05, 2022
Cutaneous and uveal melanoma: two different cancers in therapeutic needs.

Corine Bertolotto

|Feb 06, 2021
The ERK signaling pathway returns to the limelight in uveal melanomas.

Imène Krossa, Robert Ballotti, Corine Bertolotto

|Dec 05, 2020
The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?

Robert Ballotti, Yann Cheli, Corine Bertolotto

Pageof 2